News | February 19, 2022
Abbott recalls powder formula manufactured at Sturgis, Mich., plant
Recall does not include any metabolic deficiency nutrition formulas
Recall does not include any metabolic deficiency nutrition formulas
Dr. Raman has succeeded Victoria Richon
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024
Apexxnar is the first pneumococcal conjugate vaccine to help protect adults ages 18 years and older against 20 serotypes responsible for the majority of invasive disease and pneumococcal pneumonia
These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
